Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4881337 | 0.94 | ALDH1A1 (0.69) | ALDH1A1LMNANPSR1SMN1; SMN2MAPT | |
| SCHEMBL4879015 | 0.83 | MAPT (0.49) | ALDH1A1LMNASMN1; SMN2MAPTKDM4E | |
| SCHEMBL5320050 | 0.75 | ALDH1A1 (0.61) | ALDH1A1LMNANPSR1SMN1; SMN2MAPT | |
| SCHEMBL4885182 | 0.71 | ALDH1A1 (0.44) | ALDH1A1LMNANPSR1SMN1; SMN2MAPT | |
| SCHEMBL31570784 | 0.70 | LMNA (0.78) | ALDH1A1LMNANPSR1SMN1; SMN2MEN1 | |
| SCHEMBL10624841 | 0.69 | LMNA (0.79) | ALDH1A1LMNANPSR1SMN1; SMN2KDM4E | |
| SCHEMBL31570785 | 0.68 | MEN1 (0.62) | ALDH1A1LMNANPSR1SMN1; SMN2MAPT | |
| SCHEMBL8684821 | 0.68 | CCR2 (0.46) | ALDH1A1LMNASMN1; SMN2MAPTKDM4E | |
| SCHEMBL3206324 | 0.67 | ALDH1A1 (0.59) | ALDH1A1LMNANPSR1SMN1; SMN2MAPT | |
| SCHEMBL16637671 | 0.66 | ADORA2B (0.48) | ALDH1A1LMNANPSR1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080281105-A1 | Novel Quinolinium Salts and Derivatives | IMMUSOL INCORPORATED (US) | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281105-A1 | Novel Quinolinium Salts and Derivatives | NQO2, MCL1, KRAS | ALDH1A1 3206/4885LMNA 3339/4885NPSR1 3384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.